ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STXS vs VANI // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Stereotaxis Inc. (NYSE) VS. Vivani Medical Inc. (NASDAQ) • 15-METRIC TALLY: STXS 2 — VANI 2
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STXS VS. VANI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STXS VANI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 52.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -15.01% -24.79% +9.78 STXS /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 20.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 STXS /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.8 45.0 -14.20 VANI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 3.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $91.2M $102.8M -$11.6M VANI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STXS REV VANI REV STXS GROSS % VANI GROSS % STXS FCF VANI FCF
FY 2025 $32.4M $0 52.7% — -$13.7M -$25.5M
FY 2024 $26.9M $0 54.2% — -$8.5M -$21.3M
FY 2023 $26.8M $0 — — -$9.1M -$23.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STXS // BETA —
VANI // BETA —